Correlation Between CytomX Therapeutics and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Moleculin Biotech, you can compare the effects of market volatilities on CytomX Therapeutics and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Moleculin Biotech.
Diversification Opportunities for CytomX Therapeutics and Moleculin Biotech
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between CytomX and Moleculin is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Moleculin Biotech go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Moleculin Biotech
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 1.65 times less return on investment than Moleculin Biotech. But when comparing it to its historical volatility, CytomX Therapeutics is 1.62 times less risky than Moleculin Biotech. It trades about 0.03 of its potential returns per unit of risk. Moleculin Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 262.00 in Moleculin Biotech on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Moleculin Biotech or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CytomX Therapeutics vs. Moleculin Biotech
Performance |
| Timeline |
| CytomX Therapeutics |
| Moleculin Biotech |
CytomX Therapeutics and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Moleculin Biotech
The main advantage of trading using opposite CytomX Therapeutics and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
| Moleculin Biotech vs. Bright Minds Biosciences | Moleculin Biotech vs. HP Inc | Moleculin Biotech vs. Intel | Moleculin Biotech vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |